Study on Rifampin for CYP24A1-related Hypercalcemia and Hypercalciuria Initiated
A clinical trial is underway to assess the efficacy of rifampin in treating hypercalcemia and hypercalciuria linked to CYP24A1 mutations.
Therapeutic Area
Therapeutic area intelligence for Hypercalcemia with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.